COVID, Kidney Injury
Conditions
Brief summary
Novel coronavirus disease (COVID-19) is a newly discovered contagious disease caused by SARS-CoV-2 virus, primarily manifesting as an acute respiratory illness with pneumonia, but can affect multiple organs such as kidney, heart, digestive tract, blood and nervous system. In previous reports of SARS and MERS-CoV infections, acute kidney injury was described in 5 to 15% of patients and was associated with a high mortality rate (60-90%). Recent reports showed renal abnormalities in COVID-9 infected patients. A recent Chinese study also reported that acute kidney injury was an independent risk factor for mortality. However, the exact mechanism of kidney involvement remains unclear: sepsis-related cytokine storm or direct cellular injury from the virus. Also, kidney involvement has not yet been well characterized: heavy albuminuria, hematuria or interstitial nephropathy alone. A recent study identified viral RNA in kidney tissue and another study succeeded isolating SARS-CoV-2 from the urine sample of an infected patient. These data suggest that the kidney might be a target of this novel coronarivus. The sponsor suggests characterizing kidney involvement in SARS-CoV-2 infection. Study objectives are: * To give an accurate characterization of kidney involvement in COVID-19 * To investigate the physiopathologic mechanism of kidney involvement in SARS-CoV-2 infection * To identify risk factors for kidney involvement in in SARS-CoV-2 infection * To evaluate the impact of kidney involvement in in SARS-CoV-2 infection * To assess the long-term health effect of kidney injury on survivors of in SARS-CoV-2 infection
Interventions
None listed
Sponsors
Centre Hospitalier Universitaire de Nice
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Confirmed COVID-19 disease * Age \> 18 years-old
Exclusion criteria
* Age \< 18 years-old * Pregnancy * Patient with tutor- or curatorship or in prison * Patients who had undergone renal replacement therapy (RRT) before admission
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Kidney involvement in COVID-19 disease | until 3 months after discharge or death | Rate of kidney involvement in COVID-19 disease characterized by clinical and biological data |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Physiopathologic mechanism of kidney involvement in SARS-CoV-2 infection | until 3 months after discharge or death | biological data and histopathological data if available |
| To identify risk factors for kidney involvement in in SARS-CoV-2 infection | until 3 months after discharge or death | Rate of death |
| To evaluate the impact of kidney involvement in SARS-CoV-2 infection | until 3 months after discharge or death | Legnth of hopital stay |
| To assess the long-term health effect of kidney injury on survivors of SARS-CoV-2 infection in case of AKI KDIGO 2 or 3 | until 3 months after discharge | Recovery of Kidney fonction |
Countries
France
Outcome results
None listed